Jon Cuthbert

ImmunityBio (NASDAQ:IBRX) said the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for review, aiming to expand the approved use of its immunotherapy drug Anktiva to treat a wider patient base with non-muscle invasive bladder cancer (NMIBC).

Perion Network (NASDAQ:PERI), a digital advertising technology provider specializing in AI-native execution infrastructure, disclosed its financial results for the first quarter ended March 31, 2026, highlighting a heavy structural transition toward automated marketing tools.

Meta has reportedly started laying off employees in Singapore as part of a broader plan to reduce headcount by around 8,000 workers while increasing investment in artificial intelligence infrastructure.

Siren Gold (ASX:SNG) has received a regulatory setback in New Zealand after its application for a crucial mining permit was rejected.

Bankr temporarily disabled transactions after identifying an attacker who gained access to at least 14 wallets linked to its AI-powered crypto trading platform.

Bumo Sarang is sitting on roughly 49.3 billion won ($32.7 million) in unrealised losses after investing customer prepaid funds into leveraged cryptocurrency exchange-traded funds linked to Ethereum.

Talisman Mining (ASX:TLM) commenced a 4,500-metre follow-up Phase 2 aircore drilling programme at its East Peak Hill gold prospect.

Commodity Futures Trading Commission has sued the state of Minnesota and Governor Tim Walz after lawmakers approved what the agency described as the first outright state ban on prediction markets in the United States.

South Korean retail investors are withdrawing savings, fixed deposits and life insurance funds to increase exposure to SK Hynix and Samsung Electronics as both stocks trade near record highs on artificial intelligence chip demand.

James Hardie (ASX:JHX) has delivered its full-year performance, beating its own earnings guidance despite a 75% plunge in statutory net profit.